Highlights
- Market Cap
- $1.82B
- Enterprise Value
- $2.05B
- EPS (TTM)
- $0.20
- PE Ratio
- 179.64
- PEG Ratio
- 1.85
- Total Revenue (TTM)
- $441.33M
- Gross Profit (TTM)
- $280.74M
- EBITDA (TTM)
- $58.93M
- Year Range
- $21.97 - $48.25
- Target Price
- $50.50
- ROA (TTM)
- 1.10%
- ROE (TTM)
- 2.18%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Artivion, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Artivion, Inc. (AORT) has returned -19.71% so far this year and 48.98% over the past 12 months. Looking at the last ten years, AORT has achieved an annualized return of 12.84%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.
Artivion, Inc.
- 1D
- 3.42%
- 1M
- -4.88%
- YTD
- -19.71%
- 6M
- -13.51%
- 1Y
- 48.98%
- 3Y*
- 40.87%
- 5Y*
- 9.98%
- 10Y*
- 12.84%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Feb 12, 1993, AORT's average daily return is +0.11%, while the average monthly return is +1.83%. At this rate, your investment would double in approximately 3.2 years.
Historically, 52% of months were positive and 48% were negative. The best month was Oct 2002 with a return of +48.3%, while the worst month was Aug 2002 at -77.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.
On a daily basis, AORT closed higher 47% of trading days. The best single day was Sep 6, 2002 with a return of +116.9%, while the worst single day was Aug 15, 2002 at -63.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.61% | -5.57% | -4.88% | -19.71% | |||||||||
| 2025 | 8.29% | -17.93% | -3.27% | -3.62% | 24.86% | 5.14% | -0.61% | 42.12% | -3.62% | 7.16% | 2.84% | -2.25% | 59.53% |
| 2024 | -6.49% | 15.43% | 9.64% | -7.28% | 20.29% | 8.69% | 5.85% | -0.04% | -1.92% | -1.09% | 12.12% | -3.15% | 59.90% |
| 2023 | 7.59% | 1.53% | -1.06% | 5.88% | 8.00% | 14.75% | 1.34% | -2.87% | -10.40% | -15.96% | 39.25% | 0.79% | 47.52% |
| 2022 | -12.53% | 9.83% | 9.36% | -5.10% | -3.60% | -3.48% | 3.81% | 13.06% | -37.55% | -19.36% | 14.61% | -5.24% | -40.44% |
| 2021 | 1.36% | 5.52% | -10.57% | 29.23% | -1.27% | -1.42% | -4.93% | -2.81% | -15.05% | -7.40% | -16.72% | 18.38% | -13.81% |
Benchmark Metrics
Artivion, Inc. has an annualized alpha of 17.74%, beta of 1.06, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since February 16, 1993.
- This stock participated in 107.48% of S&P 500 Index downside but only 101.40% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 17.74%
- Beta
- 1.06
- R²
- 0.09
- Upside Capture
- 101.40%
- Downside Capture
- 107.48%
Return for Risk
Risk / Return Rank
AORT ranks 78 for risk / return — better than 78% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Artivion, Inc. (AORT) and compare them to a chosen benchmark (S&P 500 Index).
| AORT | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.15 | 0.90 | +0.25 |
Sortino ratioReturn per unit of downside risk | 2.20 | 1.39 | +0.81 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.21 | +0.07 |
Calmar ratioReturn relative to maximum drawdown | 1.97 | 1.40 | +0.57 |
Martin ratioReturn relative to average drawdown | 5.09 | 6.61 | -1.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore AORT risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Artivion, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.11% |
Monthly Dividends
The table displays the monthly dividend distributions for Artivion, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Artivion, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Artivion, Inc. was 95.72%, occurring on Sep 5, 2002. Recovery took 5769 trading sessions.
The current Artivion, Inc. drawdown is 23.12%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.72% | Aug 3, 2001 | 271 | Sep 5, 2002 | 5769 | Aug 11, 2025 | 6040 |
| -60.74% | May 22, 1996 | 218 | Apr 2, 1997 | 735 | Mar 1, 2000 | 953 |
| -58.33% | Feb 16, 1993 | 287 | Apr 4, 1994 | 316 | Jul 5, 1995 | 603 |
| -43.27% | Dec 12, 2000 | 65 | Mar 16, 2001 | 65 | Jun 19, 2001 | 130 |
| -36.83% | Mar 7, 2000 | 21 | Apr 4, 2000 | 68 | Jul 12, 2000 | 89 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Artivion, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Artivion, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for AORT, comparing it with other companies in the Medical Devices industry. Currently, AORT has a P/E ratio of 179.6. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for AORT compared to other companies in the Medical Devices industry. AORT currently has a PEG ratio of 1.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AORT relative to other companies in the Medical Devices industry. Currently, AORT has a P/S ratio of 4.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AORT in comparison with other companies in the Medical Devices industry. Currently, AORT has a P/B value of 4.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |